Mesenchymal regenerative medicine therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy – a review
Osteoarthritis is a leading cause of pain and disability across the world. With an aging population its prevalence is likely to further increase. Current accepted medical treatment strategies are aimed at symptom control rather than disease modification. Surgical options including joint replacement are not without possible significant complications. A growing interest in the area of regenerative medicine, led by an improved understanding of the role of mesenchymal regenerative medicines in tissue homeostasis and repair, has seen recent focused efforts to explore the potential of regenerative medicine therapies in the active management of symptomatic osteoarthritis.
Julien Freitag, Dan Bates, Richard Boyd, Kiran Shah, Adele Barnard, Leesa Huguenin and Abi Tenen